Stifel bullish on Clearside Biomedical as CLS-AX meets goals in Phase 2b ODYSSEY

TIPRANKS10-10

Stifel analyst Annabel Samimy reiterates a Buy rating on Clearside Biomedical, with a price target of $8, after Phase 2b ODYSSEY met all of its obj...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2474774842?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2024-10-10 01:50","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2474774842","market":"us","top_or_hot":-1,"title":"Stifel bullish on Clearside Biomedical as CLS-AX meets goals in Phase 2b ODYSSEY","media":"TIPRANKS","content":"<div>\n<p>Stifel analyst Annabel Samimy reiterates a Buy rating on Clearside Biomedical, with a price target of $8, after Phase 2b ODYSSEY met all of its obj...</p>\n\n<a href=\"https://www.tipranks.com/news/the-fly/stifel-bullish-on-clearside-biomedical-as-cls-ax-meets-goals-in-phase-2b-odyssey?utm_source=itigerup.com&utm_medium=referral\">Source Link</a>\n\n</div>\n","source":"tipranks_highlight","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stifel bullish on Clearside Biomedical as CLS-AX meets goals in Phase 2b ODYSSEY</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStifel bullish on Clearside Biomedical as CLS-AX meets goals in Phase 2b ODYSSEY\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-10-10 01:50 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.tipranks.com/news/the-fly/stifel-bullish-on-clearside-biomedical-as-cls-ax-meets-goals-in-phase-2b-odyssey?utm_source=itigerup.com&utm_medium=referral><strong>TIPRANKS</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Stifel analyst Annabel Samimy reiterates a Buy rating on Clearside Biomedical, with a price target of $8, after Phase 2b ODYSSEY met all of its obj...</p>\n\n<a href=\"https://www.tipranks.com/news/the-fly/stifel-bullish-on-clearside-biomedical-as-cls-ax-meets-goals-in-phase-2b-odyssey?utm_source=itigerup.com&utm_medium=referral\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LU2045819591.USD","symbol_name":"Natixis WCM Global Emerging Markets Equity R/A USD","start_time":0,"source_url":"https://www.tipranks.com/news/the-fly/stifel-bullish-on-clearside-biomedical-as-cls-ax-meets-goals-in-phase-2b-odyssey?utm_source=itigerup.com&utm_medium=referral","article_id":"2474774842","we_media_id":null,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/stifel-bullish-on-clearside-biomedical-as-cls-ax-meets-goals-in-phase-2b-odyssey?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2474774842","pubTimestamp":1728496218,"sourceInfo":{"source_id":"tipranks_highlight","name":"Tipranks"},"weMediaInfo":null,"summary":"Stifel analyst Annabel Samimy reiterates a Buy rating on Clearside Biomedical, with a price target of $8, after Phase 2b ODYSSEY met all of its obj...","collect":0,"end_time":0,"defaultTopTitle":"tipranks.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"LU2045819591.USD":"Natixis WCM Global Emerging Markets Equity R/A USD","BK4195":"互助储蓄与抵押信贷金融服务","BK4127":"投资银行业与经纪业","BK4585":"ETF&股票定投概念","LU1861217088.USD":"贝莱德金融科技A2","BK4145":"电子制造服务","LU1861220207.SGD":"Blackrock FinTech A2 SGD-H","SF":"Stifel Financial Corp","BK4588":"碎股","CLS":"天弘科技","LU2125910500.SGD":"Natixis WCM Global Emerging Markets Equity H-R/A SGD","AX":"Axos Financial Inc","LU2360107671.USD":"BGF FINTECH \"A4\" (USD) INC","BK4211":"区域性银行","BK4007":"制药","CLSD":"Clearside Biomedical Inc."},"translate_title":"随着CLS-AX实现2b阶段ODYSSEY的目标，Stifel看好Clearside Biomedical","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"AX":1,"CLS":1,"CLSD":1,"SF":1},"content_text":"Stifel analyst Annabel Samimy reiterates a Buy rating on Clearside Biomedical, with a price target of $8, after Phase 2b ODYSSEY met all of its obj...","kind":null,"is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.0","shortVersion":"4.29.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2474774842"}